Artificial intelligence and COVID-19: A multidisciplinary approach
- PMID: 32632356
- PMCID: PMC7255319
- DOI: 10.1016/j.imr.2020.100434
Artificial intelligence and COVID-19: A multidisciplinary approach
Abstract
The COVID-19 pandemic is taking a colossal toll in human suffering and lives. A significant amount of new scientific research and data sharing is underway due to the pandemic which is still rapidly spreading. There is now a growing amount of coronavirus related datasets as well as published papers that must be leveraged along with artificial intelligence (AI) to fight this pandemic by driving news approaches to drug discovery, vaccine development, and public awareness. AI can be used to mine this avalanche of new data and papers to extract new insights by cross-referencing papers and searching for patterns that AI algorithms could help discover new possible treatments or help in vaccine development. Drug discovery is not a trivial task and AI technologies like deep learning can help accelerate this process by helping predict which existing drugs, or brand-new drug-like molecules could treat COVID-19. AI techniques can also help disseminate vital information across the globe and reduce the spread of false information about COVID-19. The positive power and potential of AI must be harnessed in the fight to slow the spread of COVID-19 in order to save lives and limit the economic havoc due to this horrific disease.
Keywords: Artificial intelligence; COVID-19; Drug Discovery; Integrative medicine; Vaccine development.
© 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V.
Similar articles
-
Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine.Biomed Res Int. 2022 Jul 6;2022:7205241. doi: 10.1155/2022/7205241. eCollection 2022. Biomed Res Int. 2022. PMID: 35845955 Free PMC article. Review.
-
Artificial Intelligence (AI) applications for COVID-19 pandemic.Diabetes Metab Syndr. 2020 Jul-Aug;14(4):337-339. doi: 10.1016/j.dsx.2020.04.012. Epub 2020 Apr 14. Diabetes Metab Syndr. 2020. PMID: 32305024 Free PMC article. Review.
-
Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development.Front Artif Intell. 2020 Aug 18;3:65. doi: 10.3389/frai.2020.00065. eCollection 2020. Front Artif Intell. 2020. PMID: 33733182 Free PMC article. Review.
-
Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design.Brief Bioinform. 2021 Nov 5;22(6):bbab320. doi: 10.1093/bib/bbab320. Brief Bioinform. 2021. PMID: 34410360 Free PMC article.
-
Current Artificial Intelligence (AI) Techniques, Challenges, and Approaches in Controlling and Fighting COVID-19: A Review.Int J Environ Res Public Health. 2022 May 12;19(10):5901. doi: 10.3390/ijerph19105901. Int J Environ Res Public Health. 2022. PMID: 35627437 Free PMC article. Review.
Cited by
-
An architecture for COVID-19 analysis and detection using big data, AI, and data architectures.PLoS One. 2024 Aug 1;19(8):e0305483. doi: 10.1371/journal.pone.0305483. eCollection 2024. PLoS One. 2024. PMID: 39088543 Free PMC article.
-
Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine.Biomed Res Int. 2022 Jul 6;2022:7205241. doi: 10.1155/2022/7205241. eCollection 2022. Biomed Res Int. 2022. PMID: 35845955 Free PMC article. Review.
-
Harnessing Machine Learning in Early COVID-19 Detection and Prognosis: A Comprehensive Systematic Review.Cureus. 2023 May 1;15(5):e38373. doi: 10.7759/cureus.38373. eCollection 2023 May. Cureus. 2023. PMID: 37265897 Free PMC article. Review.
-
The Consequences of COVID-19 Disruption on Sustainable Economy in the Top 30 High-Tech Innovative Countries.Glob J Flex Syst Manag. 2023;24(2):247-269. doi: 10.1007/s40171-023-00338-z. Epub 2023 Apr 3. Glob J Flex Syst Manag. 2023. PMID: 37101930 Free PMC article.
-
The prospective of Artificial Intelligence in COVID-19 Pandemic.Health Technol (Berl). 2021;11(6):1311-1320. doi: 10.1007/s12553-021-00601-2. Epub 2021 Sep 28. Health Technol (Berl). 2021. PMID: 34603925 Free PMC article. Review.
References
-
- Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset. The White House. https://www.whitehouse.gov/briefings-statements/call-action-tech-communi.... Accessed March 24, 2020.
-
- ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifier NCT03945825, Flublok or Fluzone With Advax-CpG55.2 or AF03; 2020 March 16 [cited 2020 March 23]; Available from: https://clinicaltrials.gov/ct2/show/NCT03945825?term=Advax&cond=infl....
-
- Park A. AI develops’ turbocharged’ flu vaccine: A clinical trial will soon be underway in the U.S. to test the efficacy of an enhanced flu vaccine developed by an artificial intelligence system at Flinders University in South Australia. Becker’s Hospital Review. https://www.beckershospitalreview.com/artificial-intelligence/ai-develop.... Accessed March 24, 2020.
-
- Smith M., Smith J.C. Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral Spike Protein and viral spike protein-human ACE2 interface. ChemRxiv. 2020 doi: 10.26434/chemrxiv.11871402.v4. - DOI
-
- Reicher M. Coronavirus call centers stumble in Washington state: glitches, lack of staff, contradicting messages. The Seattle Times. https://www.seattletimes.com/seattle-news/times-watchdog/washington-coro.... Published March 17, 2020. Accessed March 20, 2020.
Publication types
LinkOut - more resources
Full Text Sources